Renata Bocciardi

Dr. Renata Bocciardi

University of Genova, DINOGMI
+1
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1994 in Nature
Verified
Journal Article
Closed access
GRGiovanni Romeo
Giovanni Romeo
PRPatrizia Ronchetto
Patrizia Ronchetto
YLYin Luo
Yin Luo
VBVirginia Barone
Virginia Barone
MSMarco Seri
Marco Seri
HKHelena K
Helena K

1 May 1995 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
Barbara PasiniBarbara Pasini
Barbara Pasini
MBMaria Grazia Borrello
Maria Grazia Borrello
Angela GrecoAngela Greco
Angela Greco
IBItalia Bongarzone
Italia Bongarzone
YLYin Luo
Yin Luo
MPMarco A. Pierotti
Marco A. Pierotti

1 July 2007 in Human Mutation
Verified
Journal Article
Closed access
PDF file
RBRenata Bocciardi
Renata Bocciardi
RGRoberto Giorda
Roberto Giorda
JBJens Buttgereit
Jens Buttgereit
SGStefania Gimelli
Stefania Gimelli
MDMaria Teresa Divizia
Maria Teresa Divizia
GGGiorgio Gimelli
Giorgio Gimelli
Longitudinal bone growth is determined by the process of endochondral ossification in the cartilaginous growth plate, which is located at both ends of vertebrae and long bones and involves many systemic hormones and local regulators. We report the molecular characterization of a de novo balanced t(2;7)(q37.1;q21.3) translocation in a young female with Marfanoid habitus and skeletal anomalies. The translocation was characterized by fluorescence in situ hybridization (FISH), checked for other abnormalities by array‐comparative genomic hybridization (CGH), and finally, the breakpoints were cloned, sequenced, and compared. Biochemical dosage was applied to study the possible mechanisms that may cause the proposita's phenotype. The breakpoint on chromosome 2 disrupts the hypothetical gene MGC42174 (HUGO‐approved symbol DIS3L2) and is located in the proximity of the NPPC gene coding for C‐type natriuretic peptide (CNP), a molecule that regulates endochondral bone growth. CNP plasma concentration was doubled in the proband compared to five normal controls, while NPPC was substantially overexpressed in her fibroblasts. A transgenic mouse generated to target NPPC overexpression in bone showed a phenotype highly reminiscent of the patient's phenotype. The breakpoint on chromosome 7 is localized proximally at about 75 kb from the COL1A2 gene. The COL1A2 allele on the derivative chromosome was strongly underexpressed in fibroblasts, but total collagen was not significantly different from controls. Several evidences support the conclusion that the proband's abnormal phenotype is associated with C‐type natriuretic peptide overexpression. Hum Mutat 28(7), 724–731, 2007.

1 November 2006 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
MMMarco Musso
Marco Musso
RBRenata Bocciardi
Renata Bocciardi
SPSara Parodi
Sara Parodi
RRRoberto Ravazzolo
Roberto Ravazzolo
Isabella CeccheriniIsabella Ceccherini
Isabella Ceccherini

1 October 2008 in European Journal of Human Genetics
Verified
Journal Article
Closed access
RBRenata Bocciardi
Renata Bocciardi
DBDomenico Bordo
Domenico Bordo
MDMarco Di Duca
Marco Di Duca
MRMaja Di Rocco
Maja Di Rocco
RRRoberto Ravazzolo
Roberto Ravazzolo

19 October 2010 in Human Mutation
Verified
Journal Article
Open access
PDF file
SGStefania Gimelli
Stefania Gimelli
GCGianluca Caridi
Gianluca Caridi
SBSilvana Beri
Silvana Beri
KMKyle McCracken
Kyle McCracken
RBRenata Bocciardi
Renata Bocciardi
Gian Marco GhiggeriGian Marco Ghiggeri
Gian Marco Ghiggeri
Congenital anomalies of the kidney and the urinary tract (CAKUT) represent a major source of morbidity and mortality in children. Several factors (PAX, SOX,WNT, RET, GDFN, and others) play critical roles during the differentiation process that leads to the formation of nephron epithelia. We have identified mutations in SOX17, an HMG‐box transcription factor and Wnt signaling antagonist, in eight patients with CAKUT (seven vesico‐ureteric reflux, one pelvic obstruction). One mutation, c.775T>A (p.Y259N), recurred in six patients. Four cases derived from two small families; renal scars with urinary infection represented the main symptom at presentation in all but two patients. Transfection studies indicated a 5–10‐fold increase in the levels of the mutant protein relative to wild‐type SOX17 in transfected kidney cells. Moreover we observed a corresponding increase in the ability of SOX17 p.Y259N to inhibit Wnt/β‐catenin transcriptional activity, which is known to regulate multiple stages of kidney and urinary tract development. In conclusion, SOX17 p.Y259N mutation is recurrent in patients with CAKUT. Our data shows that this mutation correlates with an inappropriate accumulation of SOX17‐p.Y259N protein and inhibition of the β‐catenin/Wnt signaling pathway. These data indicate a role of SOX17 in human kidney and urinary tract development and implicate the SOX17–p.Y259N mutation as a causative factor in CAKUT.Hum Mutat 31:1352–1359, 2010.